ATXS
Price
$7.19
Change
+$0.04 (+0.56%)
Updated
Sep 26, 02:54 PM (EDT)
Capitalization
403.51M
47 days until earnings call
LRMR
Price
$5.24
Change
+$0.38 (+7.82%)
Updated
Sep 26, 01:17 PM (EDT)
Capitalization
415.97M
53 days until earnings call
Interact to see
Advertisement

ATXS vs LRMR

Header iconATXS vs LRMR Comparison
Open Charts ATXS vs LRMRBanner chart's image
Astria Therapeutics
Price$7.19
Change+$0.04 (+0.56%)
Volume$293
Capitalization403.51M
Larimar Therapeutics
Price$5.24
Change+$0.38 (+7.82%)
Volume$33.26K
Capitalization415.97M
ATXS vs LRMR Comparison Chart in %
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. LRMR commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a StrongBuy and LRMR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ATXS: $7.15 vs. LRMR: $4.86)
Brand notoriety: ATXS and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 87% vs. LRMR: 167%
Market capitalization -- ATXS: $403.51M vs. LRMR: $415.97M
ATXS [@Biotechnology] is valued at $403.51M. LRMR’s [@Biotechnology] market capitalization is $415.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, LRMR is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 4 TA indicator(s) are bullish while LRMR’s TA Score has 5 bullish TA indicator(s).

  • ATXS’s TA Score: 4 bullish, 6 bearish.
  • LRMR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LRMR is a better buy in the short-term than ATXS.

Price Growth

ATXS (@Biotechnology) experienced а -4.41% price change this week, while LRMR (@Biotechnology) price change was +13.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.35%. For the same industry, the average monthly price growth was +8.65%, and the average quarterly price growth was +50.98%.

Reported Earning Dates

ATXS is expected to report earnings on Nov 12, 2025.

LRMR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+3.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LRMR($416M) and ATXS($404M) have the same market capitalization . LRMR YTD gains are higher at: 25.581 vs. ATXS (-20.022). LRMR has higher annual earnings (EBITDA): -108.21M vs. ATXS (-131.42M). ATXS has more cash in the bank: 259M vs. LRMR (139M). LRMR (4.61M) and ATXS (4.77M) have identical debt. ATXS (0) and LRMR (0) have equivalent revenues.
ATXSLRMRATXS / LRMR
Capitalization404M416M97%
EBITDA-131.42M-108.21M121%
Gain YTD-20.02225.581-78%
P/E RatioN/AN/A-
Revenue00-
Total Cash259M139M186%
Total Debt4.77M4.61M103%
FUNDAMENTALS RATINGS
ATXS vs LRMR: Fundamental Ratings
ATXS
LRMR
OUTLOOK RATING
1..100
6922
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
4537
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (33) in the null industry is in the same range as ATXS (55) in the Biotechnology industry. This means that LRMR’s stock grew similarly to ATXS’s over the last 12 months.

LRMR's Profit vs Risk Rating (100) in the null industry is in the same range as ATXS (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to ATXS’s over the last 12 months.

ATXS's SMR Rating (98) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that ATXS’s stock grew similarly to LRMR’s over the last 12 months.

LRMR's Price Growth Rating (37) in the null industry is in the same range as ATXS (45) in the Biotechnology industry. This means that LRMR’s stock grew similarly to ATXS’s over the last 12 months.

LRMR's P/E Growth Rating (100) in the null industry is in the same range as ATXS (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to ATXS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATXSLRMR
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 18 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MUNMF0.170.01
+4.52%
Mundoro Capital, Inc.
MEURX31.76N/A
N/A
Franklin Mutual International Value Z
JFNSX66.26N/A
N/A
Janus Henderson Global Life Sciences S
ERMAF58.98N/A
N/A
Eramet-SLN
ADFJF5.52-0.23
-4.00%
ADF Group Inc.

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with EYPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
-4.71%
EYPT - LRMR
49%
Loosely correlated
-6.32%
SYRE - LRMR
49%
Loosely correlated
-8.18%
ACLX - LRMR
48%
Loosely correlated
-0.44%
OCUL - LRMR
48%
Loosely correlated
-2.55%
ATXS - LRMR
47%
Loosely correlated
-1.65%
More